Physician profile
Michael Joannides
NPI 1720475858
$5,622.92
in general payments reported to CMS, 2019-2025
11 companies · $13.59 in 2025
The $13.59 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.14 · 2020: $40.88 · 2021: $4,715 · 2022: $139 · 2023: $511 · 2024: $117 · 2025: $13.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426 · Travel and Lodging: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.04 |
| Travel and Lodging | $214.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,963.21 | 2021-2024 | Da Vinci Surgical System |
| Conmed Corporation | $164.76 | 2023 | Conmed Specimen Retrieval, Airseal |
| Apollo Endosurgery US INC | $116.49 | 2021-2023 | Overstitch Endoscopic Suturing System |
| Davol INC. | $112.18 | 2022 | |
| Merck Sharp & Dohme LLC | $87.14 | 2019 | |
| Ethicon US, LLC | $49.29 | 2024 | Echelon Endopath, Echelon Flex, Harmonic |
| Melinta Therapeutics, LLC | $32.65 | 2021 | |
| Novo Nordisk INC | $31.97 | 2020-2025 | Wegovy |
| Medical Device Business Services, INC. | $27.84 | 2024 | Echelon Flex |
| Pharmacyclics LLC, An Abbvie Company | $22.50 | 2020 | |
| Lilly USA, LLC | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Joannides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.